MP
MRTX

Mangrove Partners’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Mangrove Partners’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,101,736
Closed -$64.7M – 199
2023
Q4 		$64.7M Buy
+1,101,736
New +$64.7M 4.37% 2